IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out 0 09.01.2025 22:27 MarketWatch.com IGM Biosciences is again cutting staff as it scraps an autoimmune-drug trial after failing to achieve the desired results. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
